Japanese encephalitis vaccine (live, attenuated) Completed Phase 4 Trials for Japanese Encephalitis Prevention

Indications	Status	Purpose	Phase
DBCOND0033178 (Japanese Encephalitis)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02514746	Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose	Japanese encephalitis vaccine (live, attenuated) (DB16577)
NCT01981967	Post-licensure Safety Study of IMOJEV® in Thailand	Japanese encephalitis vaccine (live, attenuated) (DB16577)